Drug-Coated Balloon Angioplasty for the Management of Recurring Infrapopliteal Disease in Diabetic Patients with Critical Limb Ischemia

To describe the 1-year outcomes of recurring infrapopliteal disease after endovascular revascularization with the Lutonix drug-coated balloons (LDCB) in diabetic patients with Critical Limb Ischemia (CLI), and to benchmark our findings with previously published objective performance goals (OPG) addressing safety and efficacy of new catheter-based therapies for CLI.

Source: Cardiovascular Revascularization Medicine - June 19, 2017 Category: Cardiology Authors: Luis M. Palena, Larry J. Diaz-Sandoval, Efren G òmez Jabalera, Olga Peypoch Perez, Enrico Sultato, Cesare Brigato, Enrico Brocco, Marco Manzi Source Type: research